|
|
|
|
LEADER |
00907naa a2200289 i 4500 |
001 |
NSK01001109803 |
003 |
HR-ZaNSK |
005 |
20210817160205.0 |
007 |
ta |
008 |
210817s2018 ci a | |0|| ||hrv |
035 |
|
|
|a (HR-ZaNSK)001109803
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
041 |
0 |
|
|a hrv
|b eng
|
042 |
|
|
|a croatica
|
044 |
|
|
|a ci
|c hr
|
080 |
1 |
|
|a 615
|2 2011
|
100 |
1 |
|
|a Vuga, Ivana
|4 aut
|
245 |
1 |
0 |
|a Direktni oralni antikoagulacijski lijekovi /
|c Ivana Vuga, Sandra Šupraha Goreta, Sandra Margetić.
|
300 |
|
|
|b Ilustr.
|
504 |
|
|
|a Bibliografija: 61 jed.
|
504 |
|
|
|a Abstract
|
653 |
|
0 |
|a Antikoagulansi
|a Novi lijekovi
|a Dabigatran
|a Rivaroksaban
|a Apiksaban
|
700 |
1 |
|
|a Šupraha Goreta, Sandra
|4 aut
|
700 |
1 |
|
|a Margetić, Sandra
|4 aut
|
773 |
0 |
|
|t Farmaceutski glasnik
|x 0014-8202
|g 74 (2018), 9 ; str. 633-651
|w nsk.(HR-ZaNSK)000000435
|
981 |
|
|
|b B14/18
|
998 |
|
|
|b gtao2108
|